−0.21EUR
−3.79 MEUR
3.91 MEUR
11.96 M
About BIORETEC OY
Sector
Industry
CEO
Timo Lehtonen
Website
Headquarters
Tampere
Employees (FY)
37
Founded
1998
ISIN
FI4000480454
FIGI
BBG011J0CZC1
Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. It specializes in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The company's products include bioabsorbable nails, pins, and screws as well as bioresorbable magnesium implants. Bioretec was founded in 1998 and is headquartered in Tampere, Finland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BRETEC is 2.70 EUR — it has decreased by 2.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange BIORETEC OY stocks are traded under the ticker BRETEC.
BIORETEC OY is going to release the next earnings report on Aug 15, 2024. Keep track of upcoming events with our Earnings Calendar.
BRETEC stock is 3.72% volatile and has beta coefficient of 0.61. Check out the list of the most volatile stocks — is BIORETEC OY there?
BRETEC earnings for the last quarter are −0.09 EUR per share, whereas the estimation was −0.08 EUR resulting in a −9.01% surprise. The estimated earnings for the next quarter are −0.08 EUR per share. See more details about BIORETEC OY earnings.
BIORETEC OY revenue for the last quarter amounts to 1.89 M EUR despite the estimated figure of 1.62 M EUR. In the next quarter revenue is expected to reach 2.30 M EUR.
Yes, you can track BIORETEC OY financials in yearly and quarterly reports right on TradingView.
BRETEC stock has fallen by 5.59% compared to the previous week, the month change is a 8.87% rise, over the last year BIORETEC OY has showed a 5.88% increase.
BRETEC net income for the last quarter is −1.71 M EUR, while the quarter before that showed −2.08 M EUR of net income which accounts for 17.42% change. Track more BIORETEC OY financial stats to get the full picture.
No, BRETEC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BRETEC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIORETEC OY stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 37.00 employees. See our rating of the largest employees — is BIORETEC OY on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIORETEC OY technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIORETEC OY stock shows the buy signal. See more of BIORETEC OY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIORETEC OY future price: according to them, BRETEC price has a max estimate of 2.80 EUR and a min estimate of 2.80 EUR. Read a more detailed BIORETEC OY forecast: see what analysts think of BIORETEC OY and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIORETEC OY EBITDA is −2.83 M EUR, and current EBITDA margin is −72.53%. See more stats in BIORETEC OY financial statements.